Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by type of product
3.2. Snippet by type of diseases
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising prevalence of retinal diseases amongst the geriatric population
4.1.2. Restraints
4.1.2.1. Shortage of Expert ophthalmologists
4.1.3. Opportunity
4.1.3.1. Increasing product launches and approvals
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. By Type of Product
7.1 Contact lens
7.2 Visual Prostheses
8. By Type of Diseases
8.1. Glaucoma
8.2. Diabetes
8.3. AMD
8.4. Retinitis Pigmentosa
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Product
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Diseases
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Johnson & Johnson
11.2. NIDEK
11.3. Novartis
11.4. Second Sight
11.5. Menicon
11.6. NJ Retina
11.7. Interojo
11.8. Pixium Vision
11.9. OcuMedic
11.10. Bausch & Lomb
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us